Glyphosate formulations and their use for the inhibition of 5-enolpyruvylshikimate-3-phosphate synthase
US7771736B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Aug 29, 2003 |
| Grant date | Aug 10, 2010 |
| Priority date | — |
| Expiry date | Sep 3, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Protozoan parasites of the phylum Apicomplexa include some of the most important causative agents of human and animal diseases, in particular, malaria. The discovery that an organelle found inside parasites of this phylum probably stems from a plastid of plant origin has stimulated research on the effect of chemical herbicidal agents on Apicomplexa. Importantly, the growth of these parasites can be inhibited by the herbicide glyphosate, suggesting that the shikimate pathway will make a good target for the development of new anti-parasite agents. The present invention discloses the use of the herbicidal agent glyphosate in combination with the polyvalent anion oxalic acid for the prevention and therapy of these pathogenic infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.